Skip to main content
Premium Trial:

Request an Annual Quote

Clear Labs, Oxford Nanopore Ink North American Distribution Agreement for Food Safety Testing

NEW YORK (GenomeWeb) – Food testing and analytics startup Clear Labs said today that it has signed a US distribution agreement with Oxford Nanopore Technologies (ONT) for rapid food-based pathogen screening technology.

As part of the agreement, Clear Labs will implement ONT's GridIon NGS platform to run its Clear Safety serotyping and detection assays on food samples. The firm said that its bioinformatics software and laboratory automation, paired with the GridIon, will help customers minimize risk, determine results in food specimens within 24 hours, and react quickly to pathogen outbreaks.

"The technology stack we've built at Clear Labs is designed specifically with our customers' needs in mind, with a focus on speed and accuracy at every step," Clear Labs CEO Sasan Amini said in a statement.

In addition to Clear Safety, Clear Labs also supports testing for authenticity, GMO, and microbiome testing.

"When [Clear Labs] approached us about leveraging GridIon in Clear Safety, we saw a unique opportunity to meet a critical business need in the industry a fast turnaround and the ability to fit into a completely automatic system," ONT CEO Gordon Sanghera said in a statement.

For more on how Clear Labs is using Oxford Nanopore sequencing in its food testing workflow, click here.

The Scan

NFTs for Genome Sharing

Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data.

Wastewater Warning System

Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19.

Networks to Boost Surveillance

Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance.

Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool

In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.